Wintest
6721
Osaka Yuka Industry
4124
D. Western Therapeutics Institute
4576
Asiro
7378
Hamee
3134
(Q2)May 31, 2024 | (Q1)Feb 29, 2024 | (FY)Nov 30, 2023 | (Q4)Nov 30, 2023 | (Q3)Aug 31, 2023 | (Q2)May 31, 2023 | (Q1)Feb 28, 2023 | (FY)Nov 30, 2022 | (Q4)Nov 30, 2022 | (FY)Nov 30, 2021 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | 89.78%776.19M | 15.39%432.21M | 17.48%1.94B | 58.72%625.33M | 531.51M | 408.99M | 374.57M | 21.26%1.65B | 393.98M | 43.46%1.36B |
Cost of revenue | 20.58%102.58M | -56.03%48.55M | -21.72%441.05M | 47.69%158.29M | 87.28M | 85.07M | 110.4M | 3.23%563.41M | 107.18M | 44.75%545.81M |
Gross profit | 107.96%673.61M | 45.24%383.66M | 37.78%1.5B | 62.84%467.03M | 444.23M | 323.92M | 264.17M | 33.32%1.09B | 286.8M | 42.61%816.24M |
Operating expense | -8.23%543.2M | -20.42%366.78M | 7.71%1.8B | -7.56%388.8M | 355.21M | 591.91M | 460.91M | 9.58%1.67B | 420.59M | 1.56%1.52B |
Operating profit | 148.66%130.41M | 108.58%16.88M | 48.71%-297.49M | 158.47%78.23M | 89.02M | -267.99M | -196.74M | 17.85%-579.99M | -133.79M | 23.80%-706.06M |
Net non-operating interest income (expenses) | -129.54%-7.75M | -23.70%-4.1M | -32.84%-14.04M | -14.64%-3.74M | -3.61M | -3.38M | -3.32M | -111.12%-10.57M | -3.27M | -55.50%-5.01M |
Non-operating interest income | ---- | ---- | -18.18%18K | -50.00%1K | ---- | ---- | ---- | -15.38%22K | --2K | -96.62%26K |
Non-operating interest expense | 129.54%7.75M | 23.70%4.1M | 32.74%14.06M | 14.60%3.74M | --3.62M | --3.38M | --3.32M | 110.47%10.59M | --3.27M | 26.17%5.03M |
Net investment income | ||||||||||
Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
Gain(Loss) on derecognition of available-for-sale financial assets | 0.39%-6.2M | -6.2M | -6.23M | 0 | 0 | |||||
Income from associates and other participating interests | -5.73M | -85.91%-9.05M | -691.49%-28.79M | -302.90%-9.88M | -14.05M | 0 | -4.87M | 4.87M | 4.87M | 0 |
Special income (charges) | 81.19%-13.44M | -14.27M | 830K | -242.32%-71.41M | 0 | -579.92%-20.86M | ||||
Less:Other special charges | ---- | ---- | -101.16%-830K | --0 | ---- | ---- | ---- | --71.41M | --0 | ---- |
Less:Write off | ---- | ---- | --14.27M | ---- | ---- | ---- | ---- | --0 | ---- | 579.92%20.86M |
Other non-operating income (expenses) | -282.99%-3.08M | -127.56%-19.07M | 1.00%-8.93M | 45.98%-5.73M | 3.49M | 1.68M | -8.38M | -156.26%-9.02M | -10.6M | 389.77%16.04M |
Income before tax | 142.23%113.9M | 92.81%-15.34M | 45.14%-368.89M | 126.90%38.42M | 75.69M | -269.69M | -213.31M | 6.08%-672.36M | -142.79M | 23.93%-715.89M |
Income tax | 6,312.72%25.72M | 113.88%894K | 128.44%3.66M | 530.15%2.51M | 328K | 401K | 418K | -15.25%1.6M | 398K | -0.37%1.89M |
Net income | 132.65%88.19M | 92.40%-16.24M | 44.72%-372.55M | 125.08%35.91M | 75.36M | -270.09M | -213.73M | 6.10%-673.96M | -143.18M | 23.89%-717.78M |
Net income continuous operations | 132.65%88.19M | 92.40%-16.24M | 44.72%-372.54M | 125.08%35.91M | --75.36M | ---270.09M | ---213.73M | 6.10%-673.96M | ---143.18M | 23.89%-717.78M |
Noncontrolling interests | 290.56%32.88M | 0 | 69.90%-33.83M | 0 | 1.5M | -17.25M | -18.08M | 24.46%-112.39M | -17.63M | -4.10%-148.79M |
Net income attributable to the company | 121.87%55.31M | 91.70%-16.24M | 39.68%-338.71M | 128.60%35.91M | 73.87M | -252.84M | -195.65M | 1.30%-561.57M | -125.56M | 28.89%-568.99M |
Preferred stock dividends | ||||||||||
Other under preferred stock dividend | 1K | 0 | 0.00%-1K | 0 | 0 | 0 | -1K | -1K | 0 | 0 |
Net income attributable to common stockholders | 121.87%55.31M | 91.70%-16.24M | 39.68%-338.71M | 128.60%35.91M | 73.87M | -252.84M | -195.65M | 1.30%-561.57M | -125.56M | 28.89%-568.99M |
Gross dividend payment | ||||||||||
Basic earnings per share | 120.31%2.46 | 92.30%-0.74 | 59.29%-16.07 | 129.36%1.95 | 3.7 | -12.11 | -9.61 | 1.31%-39.47 | -6.6411 | -0.46%-39.9947 |
Diluted earnings per share | 119.22%2.3271 | 92.30%-0.74 | 59.29%-16.07 | 124.62%1.6347 | 3.5067 | -12.11 | -9.61 | 1.31%-39.47 | -6.6411 | -0.46%-39.9947 |
Dividend per share | ||||||||||
Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |